This clinical trial is focused on studying a group of diseases known as immune-mediated inflammatory disorders. These include conditions like ulcerative colitis, alopecia areata, atopic dermatitis, and eosinophilic esophagitis. The study is testing a medication called Etrasimod Arginine, which is being developed by Pfizer Inc. The medication is being tested in the form of mini tablets, which are small tablets that can be mixed with different foods or water.
The purpose of the study is to learn more about how the body absorbs the Etrasimod Arginine mini tablets when they are mixed with different foods like applesauce, chocolate pudding, yogurt, or just water. The study will also look at how the mini tablets taste when mixed with these foods. Participants in the study will take a single dose of the mini tablets in different forms, and researchers will compare how the body absorbs the medication in each case.
The study involves healthy adult participants who will take part in a series of tests to see how the medication is absorbed and how it tastes. The study will help researchers understand the best way to deliver the medication to patients in the future. Participants will be monitored for any side effects and will provide feedback on the taste and feel of the mini tablets. This information will be used to improve the medication for future use in treating the diseases being studied.



Belgium